Alzheimer’s disease as an inflammatory disease

Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs

VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

The M1 and M2 paradigm of macrophage activation: Time for reassessment

Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Host microbiota constantly control maturation and function of microglia in the CNS

Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works

Physiology of Microglia

Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · see citing works

Inflammasomes: mechanism of action, role in disease, and therapeutics

Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340 · see citing works

Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders

Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283 · see citing works

Alzheimer’s Disease

Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125 · see citing works

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · see citing works

Inflammasomes in health and disease

Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

Immune attack: the role of inflammation in Alzheimer disease

Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · see citing works

Microglial <scp>M1/M2</scp> polarization and metabolic states

Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · see citing works

Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain

Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968 · see citing works

How neuroinflammation contributes to neurodegeneration

Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · see citing works

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,788 · see citing works

The ageing systemic milieu negatively regulates neurogenesis and cognitive function

Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763 · see citing works

A polarizing question: do M1 and M2 microglia exist?

Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573 · see citing works

Control of microglial neurotoxicity by the fractalkine receptor

Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · see citing works

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · see citing works

Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease

Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,333 · see citing works

Microglia development follows a stepwise program to regulate brain homeostasis

Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180 · see citing works

A Meta-Analysis of Cytokines in Alzheimer's Disease

Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108 · see citing works

In-vivo measurement of activated microglia in dementia

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · see citing works

Innate immunity in the central nervous system

Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · see citing works

Role of tau protein in both physiological and pathological conditions

AVILA, J., LUCAS, J. J., PÉREZ, M., & HERNÁNDEZ, F. (2004) · Physiological Reviews · doi:10.1152/physrev.00024.2003 · Cited by 1,005 · see citing works

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935 · see citing works

Review: Activation patterns of microglia and their identification in the human brain

Boche, D., Perry, V. H., & Nicoll, J. A. R. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 911 · see citing works

Origin and differentiation of microglia

Ginhoux, F., Lim, S., Hoeffel, G., Low, D., & Huber, T. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00045 · Cited by 905 · cited 2× · see citing works

Neuronal ‘On’ and ‘Off’ signals control microglia

Biber, K., Neumann, H., Inoue, K., & Boddeke, H. W. G. M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.007 · Cited by 787 · see citing works

The Genetics of Alzheimer's Disease

Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 784 · see citing works

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease

Streit, W. J., Braak, H., Xue, Q.-S., & Bechmann, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0556-6 · Cited by 727 · see citing works

The genetics of Alzheimer disease

Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727 · see citing works

Microglia: biology and pathology

Graeber, M. B., & Streit, W. J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 720 · see citing works

The role of microglia in amyloid clearance from the AD brain

Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701 · see citing works

Role of Microglia in Neurotrauma

Loane, D. J., & Byrnes, K. R. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.002 · Cited by 657 · see citing works

Regulation of Tau Pathology by the Microglial Fractalkine Receptor

Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., & Lamb, B. T. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.023 · Cited by 639 · see citing works

Inflammasomes in the CNS

Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637 · see citing works

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain

Maphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Brain · doi:10.1093/brain/awv081 · Cited by 595 · see citing works

Protective effects of NSAIDs on the development of Alzheimer disease

Vlad, S. C., Miller, D. R., Kowall, N. W., & Felson, D. T. (2008) · Neurology · doi:10.1212/01.wnl.0000311269.57716.63 · Cited by 535 · see citing works

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer, P. L., & McGeer, E. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1177-7 · Cited by 467 · see citing works

The microglial "activation" continuum: from innate to adaptive responses

Town, T., Nikolic, V., & Tan, J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-24 · Cited by 456 · see citing works

GSK-3β, a pivotal kinase in Alzheimer disease

Llorens-Marítin, M., Jurado, J., Hernández, F., & Ávila, J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00046 · Cited by 451 · see citing works

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models

Daniels, M. J. D., Rivers‐Auty, J., Schilling, T., Spencer, N. G., Watremez, W., Fasolino, V., Booth, S., White, C., Baldwin, A. G., Freeman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12504 · Cited by 445 · see citing works

Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism

Koenigsknecht-Talboo, J., & Landreth, G. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2557-04.2004 · Cited by 444 · see citing works

Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease

Yan, S. D., Zhu, H., Fu, J., Yan, S. F., Roher, A. E., Tourtellotte, W. W., Rajavashisth, T. B., Chen, X., Godman, G. C., Stern, D. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 427 · see citing works

Roles of microglia in brain development, tissue maintenance and repair

Michell‐Robinson, M. A., Touil, H., Healy, L. M., Owen, D. R., Durafourt, B. A., Bar‐Or, A., Antel, J. P., & Moore, C. S. (2015) · Brain · doi:10.1093/brain/awv066 · Cited by 421 · see citing works

Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats

Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405 · see citing works

Inflammation and Alzheimer’s disease

Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396 · see citing works

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393 · see citing works

Role of microglia in CNS inflammation

Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392 · see citing works

Review: Systemic inflammation and<scp>A</scp>lzheimer's disease

Holmes, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01307.x · Cited by 356 · see citing works

Neuron–glia crosstalk in health and disease: fractalkine and CX 3 CR1 take centre stage

Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 336 · see citing works

The LPS receptor (CD14) links innate immunity with Alzheimer's disease

Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307 · see citing works

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease

Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303 · see citing works

Microglia in Health and Disease

Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303 · see citing works

Contribution of systemic inflammation to chronic neurodegeneration

Perry, V. H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0722-x · Cited by 277 · see citing works

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice

Ittner, A., Chua, S. W., Bertz, J., Volkerling, A., van der Hoven, J., Gladbach, A., Przybyla, M., Bi, M., van Hummel, A., Stevens, C. H., et al. (2016) · Science · doi:10.1126/science.aah6205 · Cited by 263 · see citing works

Microglia and neuroprotection: implications for Alzheimer's disease

Streit, W. J. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.013 · Cited by 256 · see citing works

Microglia show altered morphology and reduced arborization in human brain during aging and <scp>A</scp>lzheimer's disease

Davies, D. S., Ma, J., Jegathees, T., & Goldsbury, C. (2017) · Brain Pathology · doi:10.1111/bpa.12456 · Cited by 251 · see citing works

Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain

Hoozemans, J. J. M., Rozemüller, A. J. M., Janssen, I., Groot, C. J. A. D., Veerhuis, R., & Eikelenboom, P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000251 · Cited by 246 · see citing works

Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo

Bolós, M., Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., & Avila, J. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150704 · Cited by 234 · see citing works

β-amyloid, microglia, and the inflammasome in Alzheimer’s disease

Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187 · see citing works

Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors

Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142356 · Cited by 176 · see citing works

Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly

Sardi, F., Fassina, L., Venturini, L., Inguscio, M., Guerriero, F., Rolfo, E., & Ricevuti, G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.09.005 · Cited by 171 · see citing works

Prevention of LPS-Induced Microglia Activation, Cytokine Production and Sickness Behavior with TLR4 Receptor Interfering Peptides

Hines, D. J., Choi, H. B., Hines, R. M., Phillips, A. G., & MacVicar, B. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060388 · Cited by 161 · see citing works

DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response

Zhong, L., Chen, X.-F., Zhang, Z.-L., Wang, Z., Shi, X.-Z., Xu, K., Zhang, Y.-W., Xu, H., & Bu, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645986 · Cited by 133 · see citing works

Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study

Rusanen, M., Ngandu, T., Laatikainen, T. K., Tuomilehto, J., Soininen, H. S., & Kivipelto, M. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310050011 · Cited by 113 · see citing works

From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia

Tremblay, M., Lecours, C., Samson, L., Sánchez-Zafra, V., & Sierra, A. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00045 · Cited by 96 · see citing works

Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?

Ferretti, M. T., & Cuello, A. C. (2011) · Current Alzheimer Research · doi:10.2174/156720511795255982 · Cited by 94 · see citing works

Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

Morihara, T., Teter, B., Yang, F., Lim, G. P., Boudinot, S. G., Boudinot, F. D., Frautschy, S. A., & Cole, G. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300668 · Cited by 94 · see citing works

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression

Go, M., Kou, J., Lim, J.-E., Yang, J., & Fukuchi, K.-I. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.073 · Cited by 87 · see citing works

The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases

Walter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.704981 · Cited by 80 · see citing works

A unique type of GSK-3 inhibitor brings new opportunities to the clinic

Licht-Murava, A., Paz, R., Vaks, L., Avrahami, L., Plotkin, B., Eisenstein, M., & Eldar-Finkelman, H. (2016) · Science Signaling · doi:10.1126/scisignal.aah7102 · Cited by 77 · see citing works

Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau

López‐González, I., Aso, E., Carmona, M., Armand‐Ugón, M., Blanco, R., Naudí, A., Cabré, R., Portero‐Otín, M., Pamplona, R., & Ferrer, I. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000241 · Cited by 75 · see citing works

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease

Lalli, M. A., Bettcher, B. M., Arcila, M. L., Garcia, G., Guzman, C., Madrigal, L., Ramirez, L., Acosta-Uribe, J., Baena, A., Wojta, K. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.131 · Cited by 73 · cited 1× · see citing works

Risk of Dementia Among Patients With Asthma: A Nationwide Longitudinal Study

Chen, M., Li, C., Tsai, C.-F., Lin, W.-C., Chang, W.-H., Chen, T., Pan, T., Su, T., & Bai, Y. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.06.003 · Cited by 72 · see citing works

CCL11 as a potential diagnostic marker for asthma?

Wu, D., Zhou, J., Bi, H., Li, L., Gao, W. Q., Huang, M., Adcock, I. M., Barnes, P. J., & Yao, X. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.917659 · Cited by 72 · see citing works

Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma

Deininger, M. H., & Schluesener, H. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00257-4 · Cited by 70 · see citing works

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection

Chen, P., Zhao, W.-J., Guo, Y., Xu, J., & Yin, M. (2016) · BioMed Research International · doi:10.1155/2016/8090918 · Cited by 70 · see citing works

Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model

Wirz, K. T. S., Bossers, K., Stargardt, A., Kamphuis, W., Swaab, D. F., Hol, E. M., & Verhaagen, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.008 · Cited by 65 · see citing works

APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease

Manocha, G. D., Floden, A. M., Rausch, K., Kulas, J. A., McGregor, B. A., Rojanathammanee, L., Puig, K. L., Puig, K. L., Karki, S., Nichols, M. R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4654-15.2016 · Cited by 64 · see citing works

Fractalkine shedding is mediated by p38 and the ADAM10 protease under pro-inflammatory conditions in human astrocytes

O’Sullivan, S. A., Gasparini, F., Mir, A. K., & Dev, K. K. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0659-7 · Cited by 55 · see citing works

TREM2 and Risk of Alzheimer’s Disease — Friend or Foe?

Tanzi, R. E. (2015) · New England Journal of Medicine · doi:10.1056/nejmcibr1503954 · Cited by 51 · see citing works

Allergy influences the inflammatory status of the brain and enhances tau‐phosphorylation

Sarlus, H., Höglund, C. O., Karshikoff, B., Wang, X., Lekander, M., Schultzberg, M., & Oprica, M. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01556.x · Cited by 48 · see citing works

Go with your gut: microbiota meet microglia

Mosher, K. I., & Wyss‐Coray, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4051 · Cited by 43 · see citing works

Forced swimming sabotages the morphological and synaptic maturation of newborn granule neurons and triggers a unique pro-inflammatory milieu in the hippocampus

Llorens-Martín, M., Jurado-Arjona, J., Bolós, M., Pallas-Bazarra, N., & Ávila, J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.019 · Cited by 43 · see citing works

Allergy Enhances Neurogenesis and Modulates Microglial Activation in the Hippocampus

Klein, B., Mrowetz, H., Thalhamer, J., Scheiblhofer, S., Weiss, R., & Aigner, L. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00169 · Cited by 38 · see citing works

Alzheimer’s disease hypothesis and related therapies

Du, X., Wang, X., & Geng, M. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0107-y · Cited by 609 · see citing works

The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.

Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466 · see citing works

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus

Zhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379 · see citing works

The integration of inflammaging in age-related diseases

Fülöp, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 356 · see citing works

Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade

Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313 · see citing works

Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model

Cone, A. S., Yuan, X., Sun, L. J., Duke, L. C., Vreones, M. P., Carrier, A. N., Kenyon, S. M., Carver, S. R., Cushing, S. D., Stimmell, A. C., et al. (2021) · Theranostics · doi:10.7150/thno.62069 · Cited by 224 · see citing works

Human Inflammaging

Fülöp, T., Larbi, A., & Witkowski, J. M. (2019) · Gerontology · doi:10.1159/000497375 · Cited by 221 · see citing works

Lipoprotein‐associated phospholipase A2: The story continues

Huang, F., Wang, K., & Shen, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21597 · Cited by 212 · see citing works

OxInflammation: From Subclinical Condition to Pathological Biomarker

Valacchi, G., Virgili, F., Cervellati, C., & Pecorelli, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00858 · Cited by 206 · see citing works

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?

Fülöp, T., Witkowski, J. M., Bourgade, K., Khalil, A., Zerif, E., Larbi, A., Hirokawa, K., Pawelec, G., Bocti, C., Lacombe, G., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00224 · Cited by 199 · see citing works

Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia

Brelstaff, J., Tolkovsky, A. M., Ghetti, B., Goedert, M., & Spillantini, M. G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.072 · Cited by 195 · see citing works

MFG‐E8 reverses microglial‐induced neurotoxic astrocyte (A1) via NF‐κB and PI3K‐Akt pathways

Xu, X., Zhang, A., Zhu, Y., He, W., Di, W., Fang, Y., & Shi, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26918 · Cited by 189 · see citing works

Understanding the Amyloid Hypothesis in Alzheimer’s Disease

Paroni, G., Bisceglia, P., & Seripa, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180802 · Cited by 186 · see citing works

Panax ginseng as an adjuvant treatment for Alzheimer's disease

Kim, H.-J., Jung, S.-W., Kim, S.-Y., Cho, I., Kim, H., Rhim, H., Kim, M., & Nah, S.-Y. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.12.008 · Cited by 160 · see citing works

Role of the peripheral innate immune system in the development of Alzheimer's disease

Page, A. Y. L., Dupuis, G., Frost, E. H., Larbi, A., Pawelec, G., Witkowski, J. M., & Fülöp, T. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.019 · Cited by 158 · see citing works

Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

Gontijo, V. S., Viegas, F. P. D., Ortiz, C. J. C., Silva, M. D. F., Damásio, C. M., Rosa, M. C., Campos, T. G., Couto, D. S., Dias, K. S. T., & Viegas, C. (2019) · Current Neuropharmacology · doi:10.2174/1385272823666191021124443 · Cited by 147 · see citing works

Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates

Zhang, F., Zhong, R., Li, S., Fu, Z., Cheng, C., Cai, H., & Le, W. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00282 · Cited by 125 · see citing works

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies

Perea, J. R., Llorens-Martı́n, M., Ávila, J., & Bolós, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00172 · Cited by 124 · see citing works

Role of Microbes in the Development of Alzheimer’s Disease: State of the Art – An International Symposium Presented at the 2017 IAGG Congress in San Francisco

Fülöp, T., Itzhaki, R. F., Balin, B. J., Judith Miklossy, A., & Barron, A. E. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00362 · Cited by 120 · see citing works

Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease

Uddin, M. S., Yu, W. S., & Lim, L. W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101417 · Cited by 118 · see citing works

Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis

Kempuraj, D., Selvakumar, G. P., Thangavel, R., Ahmed, M. E., Zaheer, S. A., Raikwar, S. P., Iyer, S. S., Bhagavan, S., Ramaswamy, S. B., & Zaheer, A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00703 · Cited by 104 · see citing works

MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease

Liang, C., Zou, T., Zhang, M., Fan, W., Zhang, T., Jiang, Y., Cai, Y., Chen, F., Chen, X., Sun, Y., et al. (2021) · Theranostics · doi:10.7150/thno.53418 · Cited by 103 · see citing works

Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress

Ren, P., Chen, J., Li, B., Zhang, M., Yang, B., Guo, X., Chen, Z., Cheng, H., Wang, P., Wang, S.-B., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3050971 · Cited by 100 · see citing works

Beneficial Effects of Spirulina Consumption on Brain Health

Trotta, T., Porro, C., Cianciulli, A., & Panaro, M. A. (2022) · Nutrients · doi:10.3390/nu14030676 · Cited by 98 · see citing works

Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis

Garbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2021) · Molecular Biology · doi:10.1134/s002689332104004x · Cited by 95 · see citing works

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease

Cheong, S. L., Tiew, J. K., Fong, Y. H., Leong, H. W., Chan, Y. M., Chan, Z. L., & Kong, E. W. J. (2022) · Pharmaceuticals · doi:10.3390/ph15121560 · Cited by 89 · see citing works

Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease

Kempuraj, D., Ahmed, M. E., Selvakumar, G. P., Thangavel, R., Dhaliwal, A. S., Dubova, I., Mentor, S., Premkumar, K., Saeed, D., Zahoor, H., et al. (2019) · The Neuroscientist · doi:10.1177/1073858419848293 · Cited by 87 · see citing works

Drug development for Alzheimer’s disease: Review

Lao, K., Ji, N., Zhang, X., Qiao, W., Tang, Z., & Gou, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474361 · Cited by 86 · see citing works

Understanding Epigenetics in the Neurodegeneration of Alzheimer’s Disease: SAMP8 Mouse Model

Griñán‐Ferré, C., Corpas, R., Puigoriol‐Illamola, D., Palomera‐Ávalos, V., Sanfeliu, C., & Pallàs, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170664 · Cited by 83 · see citing works

Role of free radicals in human inflammatory diseases

Biswas, S., Das, R., & Banerjee, E. R. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.4.596 · Cited by 92 · see citing works

The Potential Role of Dysfunctions in Neuron-Microglia Communication in the Pathogenesis of Brain Disorders

Chamera, K., Trojan, E., Szuster-Głuszczak, M., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191113101629 · Cited by 81 · see citing works

Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 86 · see citing works

Therapeutic role of rifampicin in Alzheimer's disease

Yuluğ, B., Hanoğlu, L., Ozansoy, M., Isık, D., Kılıç, Ü., Kılıç, E., & Schabitz, W. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12637 · Cited by 81 · see citing works

Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease

Jeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76 · see citing works

Clinical pet imaging of microglial activation: Implications for microglial therapeutics in alzheimer’s disease

Shen, Z., Bao, X., & Wang, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00314 · Cited by 77 · see citing works

Exposure to Environmental and Occupational Particulate Air Pollution as a Potential Contributor to Neurodegeneration and Diabetes: A Systematic Review of Epidemiological Research

Dimakakou, E., Johnston, H. J., Streftaris, G., & Cherrie, J. W. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081704 · Cited by 78 · see citing works

Remembering your A, B, C's: Alzheimer's disease and ABCA1

Lewandowski, C. T., Laham, M. S., & Thatcher, G. R. J. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.011 · Cited by 76 · see citing works

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

Munawara, U., Catanzaro, M., Xu, W., Tan, C., Hirokawa, K., Bosco, N., Dumoulin, D., Khalil, A., Larbi, A., Lévesque, S., et al. (2021) · Immunity &amp; Ageing · doi:10.1186/s12979-021-00236-x · Cited by 74 · see citing works

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives

La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74 · see citing works

C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System

Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73 · see citing works

Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects

Feng, H., Wang, C., He, W., Wu, X.-J., Li, S., Zeng, Z., Wei, M., & He, B. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0374-4 · Cited by 72 · see citing works

Toll-like receptors in Alzheimer's disease

Momtazmanesh, S., Perry, G. L., & Rezaei, N. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577362 · Cited by 71 · see citing works

MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms

Dehghani, R., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0042 · Cited by 72 · see citing works

Anti-inflammatory and immunomodulatory effects of baicalin in cerebrovascular and neurological disorders

Li, Y., Song, K., Zhang, H., Yuan, M., An, N., Wei, Y., Wang, L., Sun, Y., Xing, Y., & Gao, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.016 · Cited by 70 · see citing works

Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship

Li, J., Sun, M., Cui, X., & Li, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710020 · Cited by 70 · see citing works

Role of extracellular vesicles in neurodegenerative diseases

Xiao, Y., Wang, S.-K., Zhang, Y., Rostami, A. M., Kenkare, A., Casella, G., Yuan, Z., & Li, X. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102022 · Cited by 67 · see citing works

Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer’s Disease

Kim, S.-J., Chung, H., Mai, H. N., Nam, Y., Shin, S. J., Park, Y., Chung, M. J., Lee, J. K., Rhee, H. Y., Jahng, G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124532 · Cited by 66 · see citing works

The Role of Microglia in the Development of Neurodegenerative Diseases

Lee, J., Chun, W., Lee, H. J., Kim, S., Min, J., Kim, D.-Y., Kim, M.-O., Ryu, H. W., & Lee, S. U. (2021) · Biomedicines · doi:10.3390/biomedicines9101449 · Cited by 63 · see citing works

Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients

Page, A. Y. L., Garneau, H., Dupuis, G., Frost, E. H., Larbi, A., Witkowski, J. M., Pawelec, G., & Fülöp, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00783 · Cited by 65 · see citing works

Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation

Mastinu, A., Premoli, M., Ferrari‐Toninelli, G., Tambaro, S., Maccarinelli, G., Memo, M., & Bonini, S. A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0013 · Cited by 60 · see citing works

Hypoxia-Induced Neuroinflammation in Alzheimer’s Disease: Potential Neuroprotective Effects of Centella asiatica

Hambali, A., Kumar, J., Hashim, N. F. M., Maniam, S., Mehat, M. Z., Cheema, M. S., Mustapha, M., Adenan, M. I., Stanslas, J., & Hamid, H. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.712317 · Cited by 62 · see citing works

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Komorowska, J., Wątroba, M., & Szukiewicz, D. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.08.002 · Cited by 59 · see citing works

Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents

Panek, D., Więckowska, A., Jończyk, J., Godyń, J., Bajda, M., Wichur, T., Pasieka, A., Knez, D., Pišlar, A. H., Korábečný, J., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00461 · Cited by 58 · see citing works

Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons

Dong, Y., Pu, K., Duan, W., Chen, H., Chen, L., & Wang, Y. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0455-7 · Cited by 58 · see citing works

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease?

Fülöp, T., Witkowski, J. M., Larbi, A., Khalil, A., Herbein, G., & Frost, E. H. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00732-3 · Cited by 58 · see citing works

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease

Perea, J. R., Lleó, A., Alcolea, D. A., Fortea, J., Ávila, J., & Bolós, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00609 · Cited by 57 · see citing works

Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β

Fernando, W. M. A. D. B., Rainey‐Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., Macaulay, S. L., Brown, B. M., Gupta, V. B., Sohrabi, H. R., Weinborn, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170742 · Cited by 56 · see citing works

Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway

Perea, J. R., Ávila, J., & Bolós, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.007 · Cited by 54 · see citing works

Expression Profiles of Long Noncoding RNAs in Intranasal LPS-Mediated Alzheimer’s Disease Model in Mice

Tang, L., Liu, L., Li, G., Jiang, P., Wang, Y., & Li, J. (2019) · BioMed Research International · doi:10.1155/2019/9642589 · Cited by 55 · see citing works

Chemicals used for the induction of Alzheimer’s disease-like cognitive dysfunctions in rodents

Mahdi, O., Baharuldin, M. T. H., Nor, N. H. M., Chiroma, S. M., Jagadeesan, S., & Moklas, M. A. M. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i11.575 · Cited by 51 · see citing works

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes

Stanciu, G. D., Rusu, R. N., Bild, V., Filipiuc, L. E., Tamba, B.-I., & Ababei, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050576 · Cited by 47 · see citing works

CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer’s disease

Zhang, L., Xu, J., Gao, J., Wu, Y., Yin, M., & Zhao, W. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0084 · Cited by 47 · see citing works

Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System

Park, S., & Wu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113574 · Cited by 46 · see citing works

Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis

Katsipis, G., Tzekaki, E. E., Tsolaki, M., & Pantazaki, Α. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577744 · Cited by 47 · see citing works

Cellular Senescence, Neurological Function, and Redox State

Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González‐Puertos, V. Y., López‐Díazguerrero, N. E., Torres, C. A., Castro‐Obregón, S., & Königsberg, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45 · see citing works

Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)

Wang, N., Qiu, P., Cui, W., Yan, X., Zhang, B., & He, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181203124102 · Cited by 45 · see citing works

Aβ Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells

Wu, Z., Tang, W., Ibrahim, F. E. E. M., Chen, X., Yan, H., Tao, C., Wang, Z., Guo, Y., Fu, Y., Wang, Q., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03945-5 · Cited by 45 · see citing works

PPARγ coactivator-1α (PGC-1α) protects neuroblastoma cells against amyloid-beta (Aβ) induced cell death and neuroinflammation via NF-κB pathway

Zhang, Y., Chen, C., Jiang, Y., Wang, S., Wu, X., & Wang, K. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0387-7 · Cited by 43 · see citing works

The distinct structural preferences of tau protein repeat domains

Li, X., Dong, X., Wei, G., Margittai, M., Nussinov, R., & Ma, B. (2018) · Chemical Communications · doi:10.1039/c8cc01263f · Cited by 42 · see citing works

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models

Corsetti, V., Borreca, A., Latina, V., Giacovazzo, G., Pignataro, A., Krashia, P., Natale, F., Cocco, S., Rinaudo, M., Malerba, F., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa039 · Cited by 41 · see citing works

Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly

Congdon, E. E., Jiang, Y., & Sigurdsson, E. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.12.002 · Cited by 37 · see citing works

RNA Sequencing Reveals Small and Variable Contributions of Infectious Agents to Transcriptomes of Postmortem Nervous Tissues From Amyotrophic Lateral Sclerosis, Alzheimer’s Disease and Parkinson’s Disease Subjects, and Increased Expression of Genes From Disease-Activated Microglia

Bennett, J. P., Keeney, P. M., & Brohawn, D. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00235 · Cited by 38 · see citing works

Klotho an Autophagy Stimulator as a Potential Therapeutic Target for Alzheimer’s Disease: A Review

Fung, T., Iyaswamy, A., Sreenivasmurthy, S. G., Krishnamoorthi, S., Guan, X.-J., Zhu, Z., Su, C.-F., Liu, J., Kan, Y., Zhang, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030705 · Cited by 41 · see citing works

Identification of P2Y receptors involved in oleamide-suppressing inflammatory responses in murine microglia and human dendritic cells

Kita, M., Ano, Y., Inoue, A., & Aoki, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40008-8 · Cited by 38 · see citing works

Oral microbiome and serological analyses on association of Alzheimer's disease and periodontitis

Fu, K., Chiu, M., Wara‐aswapati, N., Yang, C., Chang, L., Guo, Y. L., Ni, Y., & Chen, Y. (2022) · Oral Diseases · doi:10.1111/odi.14348 · Cited by 38 · see citing works

Hydroxysafflor Yellow A Inhibits Aβ1–42-Induced Neuroinflammation by Modulating the Phenotypic Transformation of Microglia via TREM2/TLR4/NF-κB Pathway in BV-2 Cells

Ren, M., Zhang, M., Zhang, X., Wang, C., Zheng, Y., & Hu, Y. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03484-x · Cited by 34 · see citing works

Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease

Fülöp, T., Munawara, U., Larbi, A., Desroches, M., Rodrigues, S., Catanzaro, M., Guidolin, A., Khalil, A., Bernier, F., Barron, A. E., et al. (2020) · CNS Drugs · doi:10.1007/s40263-020-00737-1 · Cited by 32 · see citing works

Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

Piniella‐Matamoros, B., Marín‐Prida, J., & Pentón‐Rol, G. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00161-7 · Cited by 34 · see citing works

Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History

Bermejo‐Pareja, F., & del Ser, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020536 · Cited by 35 · see citing works

Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway

Ding, R.-R., Chen, W., Guo, C.-Y., Liao, W.-T., Yang, X., Liao, F.-E., Lin, J.-M., Mei, H., & Zeng, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.108 · Cited by 33 · see citing works

Pathophysiological Aspects of Inflammation and Drug Design: an Updated Overview

Etienne, R., Viegas, F. P. D., & Viegas, C. (2020) · Revista Virtual de Química · doi:10.21577/1984-6835.20200138 · Cited by 46 · see citing works

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice

Kong, Y., Liu, K., Hua, T., Zhang, C., Sun, B., & Guan, Y. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.523798 · Cited by 30 · see citing works

Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer’s Disease and Mild Cognitive Impairment patients

Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, A. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577561 · Cited by 31 · see citing works

The Transient Receptor Potential Melastatin 7 (TRPM7) Inhibitors Suppress Seizure-Induced Neuron Death by Inhibiting Zinc Neurotoxicity

Jeong, J. H., Lee, S. H., Kho, A. R., Hong, D. K., Kang, D. H., Kang, B. S., Park, M. K., Choi, B. Y., Choi, H., Lim, M. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217897 · Cited by 30 · see citing works

Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer’s Disease Protofibril Core

Leonard, C., Phillips, C., & McCarty, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.624302 · Cited by 29 · see citing works

Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters

Pasieka, A., Panek, D., Jończyk, J., Godyń, J., Szałaj, N., Latacz, G., Tabor, J., Mezeiová, E., Chantegreil, F., Dias, J., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113397 · Cited by 30 · see citing works

The Application of Convolutional Neural Network Model in Diagnosis and Nursing of MR Imaging in Alzheimer's Disease

Chen, X., Li, L., Sharma, A., Dhiman, G., & Vimal, S. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00450-7 · Cited by 30 · see citing works

Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases

Narayanankutty, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190222181506 · Cited by 29 · see citing works

Etiology and management of Alzheimer’s disease: Potential role of gut microbiota modulation with probiotics supplementation

Dasriya, V. L., Samtiya, M., Dhewa, T., Puniya, M., Kumar, S., Ranveer, S. A., Chaudhary, V., Vij, S., Behare, P. V., Singh, N., et al. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.14043 · Cited by 29 · see citing works

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

Fülöp, T., Tripathi, S., Rodrigues, S., Desroches, M., Bunt, T., Eiser, A. R., Bernier, F., Beauregard, P. B., Barron, A. E., Khalil, A., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264910 · Cited by 27 · see citing works

Potential long‐term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans

Zheng, C., Fillmore, N. R., Ramos‐Cejudo, J., Brophy, M. T., Osorio, R. S., Gurney, M. E., Qiu, W. Q., Au, R., Perry, G. L., Dubreuil, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12465 · Cited by 27 · see citing works

Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease

Chávez-Castillo, M., Gotera, M. P., Durán, P., Diaz, M. P., Nava, M., Cano, C., Díaz-Camargo, E. A., Cano, G., Cano, R., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30153057 · Cited by 26 · see citing works

Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment

Qin, Q., & Li, Y. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25481 · Cited by 26 · see citing works

Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease

Neha, N., & Parvez, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101815 · Cited by 26 · see citing works

Long-term administration of resveratrol at low doses improves neurocognitive performance as well as cerebral blood flow and modulates the inflammatory pathways in the brain

Garrigue, P., Mounien, L., Champion, S., Mouhajir, Y., Pechère, L., Guillet, B. A., Landrier, J., & Sérée, E. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108786 · Cited by 25 · see citing works

Neuroprotective Effects of Flavonoid Compounds on Neuronal Death Associated to Alzheimer’s Disease

Sureda, A., Capó, X., & Tejada, S. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171226103237 · Cited by 25 · see citing works

The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors

Cao, K., Dong, Y.-T., Xiang, J., Xu, Y., Li, Y., Song, H., Yu, W.-F., Qi, X.-L., & Guan, Z. (2020) · Aging · doi:10.18632/aging.102713 · Cited by 22 · see citing works

Non-linear relationship of serum albumin-to-globulin ratio and cognitive function in American older people: a cross-sectional national health and nutrition examination survey 2011–2014 (NHANES) study

Yang, H., Liao, Z., Zhou, Y., Gao, Z., & Mao, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1375379 · Cited by 25 · see citing works

Melatonin in Synaptic Impairments of Alzheimer’s Disease

Shi, Y., Fang, Y., Wei, Y., Jiang, Q., Zeng, P. H., Tang, N., Lu, Y., & Tian, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171178 · Cited by 24 · see citing works

The Alz-tau Biomarker for Alzheimer’s Disease: Study in a Caucasian Population

Guzmán‐Martínez, L., Tapia, J. P., Farias, G. A., González, A., Estrella, M., & Maccioni, R. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180637 · Cited by 24 · see citing works

Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices

Wang, H., Shen, Y., Chuang, H.-Y., Chiu, C., Ye, Y., & Zhao, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503151648 · Cited by 42 · see citing works

Inflammatory aspects of Alzheimer’s disease

Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 143 · see citing works

Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches

Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 40 · see citing works

Research Advances in the Neuroinflammation in Alzheimer's Disease.

Ma, W., Zhang, X., & Wu, Q. (2017) · PubMed · doi:10.3881/j.issn.1000-503x.2017.05.019 · Cited by 4 · see citing works

Alzheimer’s disease

Azizi, G., & Mirshafiey, A. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_98 · Cited by 1 · see citing works